Partner Fund Management L.P. 13D and 13G filings for Werewolf Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-08-14 4:48 pm Sale | 2025-06-30 | 13G | Werewolf Therapeutics, Inc. HOWL | Partner Fund Management L.P. | 401,110 0.900% | -2,504,355 (-86.19%) | Filing |
| 2025-02-14 4:07 pm Purchase | 2024-12-31 | 13G | Werewolf Therapeutics, Inc. HOWL | Partner Fund Management L.P. | 2,905,465 6.500% | 2,905,465 (New Position) | Filing |